{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:31:51Z","timestamp":1790188311416,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold>The farnesoid X receptor (FXR) is a key factor regulating hepatic bile acid synthesis and enterohepatic circulation. Repression of bile acid synthesis by the FXR is a potential strategy for treating cholestatic liver disease. However, the role of intestinal FXR on the intestinal barrier and intestinal microbiota needs further investigation.<\/jats:p><jats:p><jats:bold>Materials:<\/jats:bold>Intestinal tissues were collected from patients with biliary atresia or without hepatobiliary disease. Then, intestinal mRNA levels of FXR-related molecules were determined. To investigate the effect of FXR activation, bile-duct-ligation rats were treated with obeticholic acid [OCA (5\u00a0mg\/kg\/day)] or vehicle (0.5% methyl cellulose) per oral gavage for 14\u00a0days. The mRNA levels of intestinal FXR, SHP, TNF-\u03b1, FGF15 and bile acid transporter levels were determined. In addition, the intestinal permeability, morphologic changes, and composition of the intestinal microbiota were evaluated. Gut Microbiome was determined by 16S rDNA MiSeq sequencing, and functional profiling of microbial communities was predicted with BugBase and PICRUSt2. Finally, the role of OCA in injured intestinal epithelial cell apoptosis and proliferation was examined by pretreatment with lipopolysaccharide (LPS) in Caco-2 cells.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>The downstream of the FXR in ileum tissues was inhibited in biliary obstruction. Activation of the FXR signaling pathway by OCA significantly reduced liver fibrosis and intestinal inflammation, improved intestinal microbiota, and protected intestinal mucosa in BDL rats. OCA also altered the functional capacities of ileum microbiota in BDL rats. Significant differences existed between the controls and BDL rats, which were attenuated by OCA in the alpha diversity analysis. Principal coordinates analysis showed that microbial communities in BDL rats clustered separately from controls, and OCA treatment attenuated the distinction. Bugbase and PICRUSt2 analysis showed that OCA changed the composition and structure of the intestinal microbiota and improved the metabolic function of the intestinal microbiota by increasing the relative abundance of beneficial bacteria and reducing the relative abundance of harmful bacteria. Moreover, OCA reduced the apoptosis induced by LPS in Caco-2 cells.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold>The FXR agonist, OCA, activates the intestinal FXR signaling pathway and improves the composition and structure of the intestinal microbiota and intestinal barrier in BDL rats.<\/jats:p>","DOI":"10.3389\/fphar.2022.906452","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T05:28:30Z","timestamp":1655098110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of Intestinal FXR-Related Molecules on Intestinal Mucosal Barriers in Biliary Tract Obstruction"],"prefix":"10.3389","volume":"13","author":[{"given":"Meng","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.3390\/ijms22158070","article-title":"Bifidobacterium Bifidum Enhances the Intestinal Epithelial Tight Junction Barrier and Protects against Intestinal Inflammation by Targeting the Toll-like Receptor-2 Pathway in an NF-\u03bab-independent Manner","volume":"22","author":"Al-Sadi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1053\/j.gastro.2006.11.016","article-title":"Chronic Ethanol Consumption Impairs Cellular Immune Responses against HCV NS5 Protein Due to Dendritic Cell Dysfunction","volume":"132","author":"Aloman","year":"2007","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","article-title":"The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases","volume":"26","author":"An","year":"2022","journal-title":"J. Gastrointest. Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrgastro.2015.74","article-title":"Pathogenesis of Biliary Atresia: Defining Biology to Understand Clinical Phenotypes","volume":"12","author":"Asai","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.3748\/wjg.v13.i48.6458","article-title":"Pathophysiology of Increased Intestinal Permeability in Obstructive Jaundice","volume":"13","author":"Assimakopoulos","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.0001-6772.2003.01229.x","article-title":"Evidence for Intestinal Oxidative Stress in Obstructive Jaundice-Induced Gut Barrier Dysfunction in Rats","volume":"180","author":"Assimakopoulos","year":"2004","journal-title":"Acta Physiol. Scand."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.bbadis.2017.09.019","article-title":"Nuclear Receptor FXR, Bile Acids and Liver Damage: Introducing the Progressive Familial Intrahepatic Cholestasis with FXR Mutations","volume":"1864","author":"Cariello","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0065-3101(24)00035-5","article-title":"Protective Nutrients and Bacterial Colonization in the Immature Human Gut","volume":"46","author":"Dai","year":"1999","journal-title":"Adv. Pediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-642-14541-4_4","article-title":"Role of the Intestinal Bile Acid Transporters in Bile Acid and Drug Disposition","volume":"201","author":"Dawson","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"12022","DOI":"10.1039\/d1fo02405a","article-title":"Lactobacillus Casei ATCC 393 and It's Metabolites Alleviate Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice through the NLRP3-(Caspase-1)\/IL-1\u03b2 Pathway","volume":"12","author":"Dou","year":"2021","journal-title":"Food Funct."},{"key":"B11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary Bile Acids in Hepatobiliary Injury - what Is the Link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X Receptor Activation Inhibits Inflammation and Preserves the Intestinal Barrier in Inflammatory Bowel Disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000450908","article-title":"Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease","volume":"35","author":"Gonzalez","year":"2017","journal-title":"Dig. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tcm.2015.10.004","article-title":"Metabolic Syndrome Update","volume":"26","author":"Grundy","year":"2016","journal-title":"Trends Cardiovasc Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/hep.29676","article-title":"Modulation of the Intestinal Bile Acid\/farnesoid X Receptor\/fibroblast Growth Factor 15 axis Improves Alcoholic Liver Disease in Mice","volume":"67","author":"Hartmann","year":"2018","journal-title":"Hepatology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/SHK.0b013e31818349ea","article-title":"Does Prolonged Biliary Obstructive Jaundice Sensitize the Liver to Endotoxemia?","volume":"31","author":"Iida","year":"2009","journal-title":"Shock"},{"key":"B18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal Farnesoid X Receptor Signaling Promotes Nonalcoholic Fatty Liver Disease","volume":"125","author":"Jiang","year":"","journal-title":"J. Clin. Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective Farnesoid X Receptor Inhibition Improves Obesity-Related Metabolic Dysfunction","volume":"6","author":"Jiang","year":"","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0804437105","article-title":"Functional and Comparative Metagenomic Analysis of Bile Salt Hydrolase Activity in the Human Gut Microbiome","volume":"105","author":"Jones","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/164_2019_231","article-title":"Targeting FXR in Cholestasis","volume":"256","author":"Keitel","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000324127","article-title":"TGR5 in the Biliary Tree","volume":"29","author":"Keitel","year":"2011","journal-title":"Dig. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of Tissue-specific Farnesoid X Receptor in Suppressing the Expression of Genes in Bile-Acid Synthesis in Mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21037\/tgh.2020.02.18","article-title":"Gut Microbiome Changes in Nonalcoholic Fatty Liver Disease & Alcoholic Liver Disease","volume":"6","author":"Kwong","year":"2021","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nature25010","article-title":"Structures of \u03b2-klotho Reveal a 'zip Code'-like Mechanism for Endocrine FGF Signalling","volume":"553","author":"Lee","year":"2018","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/0016-5085(90)90833-m","article-title":"Hepatic Inflammation in Rats with Experimental Small Intestinal Bacterial Overgrowth","volume":"98","author":"Lichtman","year":"1990","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/hep.30975","article-title":"Probiotic Lactobacillus Rhamnosus GG Prevents Liver Fibrosis through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.3390\/microorganisms9102086","article-title":"Alleviative Effects of Exopolysaccharide Produced by Lactobacillus Helveticus KLDS1.8701 on Dextran Sulfate Sodium-Induced Colitis in Mice","volume":"9","author":"Liu","year":"2021","journal-title":"Microorganisms"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.3390\/ijms23073710","article-title":"Histamine Causes Pyroptosis of Liver by Regulating Gut-Liver Axis in Mice","volume":"23","author":"Luo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1128\/JVI.80.2.866-874.2006","article-title":"Hepatitis C Virus Induces Toll-like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6","volume":"80","author":"Machida","year":"2006","journal-title":"J. Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a Nuclear Receptor for Bile Acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","article-title":"Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice against Cholestasis","volume":"142","author":"Modica","year":"2012","journal-title":"Gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e2100619","DOI":"10.1002\/mnfr.202100619","article-title":"Effect of Lactobacillus Rhamnosus MN-431 Producing Indole Derivatives on Complementary Feeding-Induced Diarrhea Rat Pups through the Enhancement of the Intestinal Barrier Function[J]","volume":"2021","author":"Niu","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1096\/fasebj.8.2.8119492","article-title":"Bacterial Endotoxin: Molecular Relationships of Structure to Activity and Function","volume":"8","author":"Rietschel","year":"1994","journal-title":"Faseb J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-Beta-Muricholic Acid, a Naturally Occurring FXR Antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.jhep.2017.11.025","article-title":"Role of Bile Acids in the Gut-Liver axis","volume":"68","author":"Schneider","year":"2018","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"698900","DOI":"10.3389\/fimmu.2021.698900","article-title":"Association of Gut Microbiota and Metabolites with Disease Progression in Children with Biliary Atresia","volume":"12","author":"Song","year":"2021","journal-title":"Front. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jhep.2019.06.017","article-title":"FXR Modulates the Gut-Vascular Barrier by Regulating the Entry Sites for Bacterial Translocation in Experimental Cirrhosis","volume":"71","author":"Sorribas","year":"2019","journal-title":"J. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1155\/2012\/538452","article-title":"The Impact of Farnesoid X Receptor Activation on Intestinal Permeability in Inflammatory Bowel Disease","volume":"26","author":"Stojancevic","year":"2012","journal-title":"Can. J. Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"389537","DOI":"10.1155\/2013\/389537","article-title":"Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis","volume":"2013","author":"Tabibian","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1017\/S0029665116002834","article-title":"Intestinal Bile Acid Receptors Are Key Regulators of Glucose Homeostasis","volume":"76","author":"Trabelsi","year":"2017","journal-title":"Proc. Nutr. Soc."},{"key":"B42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel Therapeutic Targets for Cholestatic and Fatty Liver Disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1042\/CS20200452","article-title":"Obeticholic Acid Ameliorates Hepatorenal Syndrome in Ascitic Cirrhotic Rats by Down-Regulating the Renal 8-Iso-Pgf2\u03b1-Activated COX-TXA2 Pathway","volume":"134","author":"Tsai","year":"2020","journal-title":"Clin. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","article-title":"The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity","volume":"183","author":"Vavassori","year":"2009","journal-title":"J. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajpath.2014.10.009","article-title":"The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats","volume":"185","author":"Verbeke","year":"2015","journal-title":"Am. J. Pathol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/jgh.14777","article-title":"Gut Microbial Profile in Biliary Atresia: a Case-Control Study","volume":"35","author":"Wang","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/00365520903406701","article-title":"Evidence for Tight Junction Protein Disruption in Intestinal Mucosa of Malignant Obstructive Jaundice Patients","volume":"45","author":"Wang","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-326987","author":"Wang","year":"2022","journal-title":"FOXA2 Prevents Hyperbilirubinaemia in Acute Liver Failure by Maintaining Apical MRP2 Expression Gut Published Online First"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.biopha.2017.11.083","article-title":"Obeticholic Acid Protects Mice against Lipopolysaccharide-Induced Liver Injury and Inflammation","volume":"96","author":"Xiong","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"skab128","DOI":"10.1093\/jas\/skab128","article-title":"Early Supplementation with Lactobacillus Plantarum in Liquid Diet Modulates Intestinal Innate Immunity through Toll-like Receptor 4-mediated Mitogen-Activated Protein Kinase Signaling Pathways in Young Piglets Challenged with Escherichia coli K88","volume":"99","author":"Yang","year":"2021","journal-title":"J. Anim. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2006.12.168","article-title":"Involvement of Membrane-type Bile Acid Receptor M-BAR\/TGR5 in Bile Acid-Induced Activation of Epidermal Growth Factor Receptor and Mitogen-Activated Protein Kinases in Gastric Carcinoma Cells","volume":"354","author":"Yasuda","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"106442","DOI":"10.1016\/j.intimp.2020.106442","article-title":"The Protective Effect of Obeticholic Acid on Lipopolysaccharide-Induced Disorder of Maternal Bile Acid Metabolism in Pregnant Mice","volume":"83","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"10783","DOI":"10.1039\/d1fo02517a","article-title":"Depletion of Gut Secretory Immunoglobulin A Coated Lactobacillus Reuteri Is Associated with Gestational Diabetes Mellitus-Related Intestinal Mucosal Barrier Damage","volume":"12","author":"Zhang","year":"2021","journal-title":"Food Funct."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.906452\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T21:00:23Z","timestamp":1727384423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.906452\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":53,"alternative-id":["10.3389\/fphar.2022.906452"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.906452","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"article-number":"906452"}}